iTeos Therapeutics Set to Join S&P SmallCap 600
iTeos Therapeutics (NASDAQ: ITOS) will replace Magellan Health (NASDAQ: MGLN) in the S&P SmallCap 600, effective January 5, 2022. This change coincides with Centene Corp. (NYSE: CNC) acquiring Magellan Health, pending final conditions. The adjustment is significant for iTeos as inclusion in a prominent index like the S&P SmallCap 600 can potentially improve market visibility and investor interest. This strategic move highlights the dynamic shifts within the healthcare sector as companies adapt to evolving market conditions.
- Inclusion in the S&P SmallCap 600 can enhance market visibility and attract more investors.
- The acquisition of Magellan Health by Centene Corp. reflects ongoing consolidation in the healthcare sector.
- None.
NEW YORK, Dec. 31, 2021 /PRNewswire/ -- iTeos Therapeutics Inc. (NASD: ITOS) will replace Magellan Health Inc. (NASD: MGLN) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, January 5. S&P 500 constituent Centene Corp. (NYSE: CNC) is acquiring Magellan Health in a deal expected to be completed soon pending final conditions.
Following is a summary of the changes that will take place prior to the open of trading on the effective date:
Effective Date | Index Name | Action | Company Name | Ticker | GICS Sector |
January 5, 2022 | S&P SmallCap 600 | Addition | iTeos Therapeutics | ITOS | Health Care |
S&P SmallCap 600 | Deletion | Magellan Health | MGLN | Health Care |
For more information about S&P Dow Jones Indices, please visit www.spdji.com
ABOUT S&P DOW JONES INDICES
S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.
S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.
FOR MORE INFORMATION:
S&P Dow Jones Indices
index_services@spglobal.com
Media Inquiries
spdji.comms@spglobal.com
View original content:https://www.prnewswire.com/news-releases/iteos-therapeutics-set-to-join-sp-smallcap-600-301452438.html
SOURCE S&P Dow Jones Indices
FAQ
What is the effective date for iTeos Therapeutics joining the S&P SmallCap 600?
Which company is being replaced by iTeos Therapeutics in the S&P SmallCap 600?
What acquisition is related to the news about iTeos Therapeutics?
Why is iTeos Therapeutics's inclusion in the S&P SmallCap 600 important?
What are the stock symbols involved in this press release?
